J Virol. 1990 February; 64(2): 731-741
Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein.
T M Gallagher,
S E Parker and
M J Buchmeier
Department of Immunology, Scripps Clinic and Research Foundation, La Jolla, California 92037.
ABSTRACT
Neuroattenuated variants of mouse hepatitis virus type 4 (MHV-4) selected for resistance to neutralizing monoclonal antibodies (R.G. Dalziel, P.W. Lampert, P. J. Talbot, and M. J. Buchmeier, J. Virol. 59:463-471, 1986) were found to harbor large deletions in both mRNA 3 and its protein product, the 180-kilodalton viron spike (S) glycoprotein. By using antipeptide antibodies directed against selected portions of the chain, deletions were mapped to the middle of the amino-terminal S1 fragment, one of the two posttranslational cleavage products of S, and involved omission of 15 kilodaltons of protein. Deletion mutants could be selected only after multiple passage of virus through cultured cell lines; minimally passaged MHV-4 stocks contained putative point mutants selectable by neutralizing monoclonal antibodies but no deletions. Enhanced growth of deletion mutants relative to wild-type virus was observed in four cell lines used for virus propagation and was attributed to delayed and diminished cytopathic effects that allowed cultures to support virus production for prolonged periods. This hypothesis was reinforced by the finding that no selective advantage for the deletion mutants was observed in two cell lines resistant to virus-induced cytopathic effects. These results indicate that the passaging of MHV-4 in culture generates heterogeneity in S structure and eventually selects for rare neutralization-resistant deletion mutants with decreased virulence properties.
J Virol. 1990 February; 64(2): 731-741
This article has been cited by other articles:
-
Weiss, S. R., Navas-Martin, S.
(2005). Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus. Microbiol. Mol. Biol. Rev.
69: 635-664
[Abstract]
[Full Text]
-
Navas-Martin, S., Hingley, S. T., Weiss, S. R.
(2005). Murine Coronavirus Evolution In Vivo: Functional Compensation of a Detrimental Amino Acid Substitution in the Receptor Binding Domain of the Spike Glycoprotein. J. Virol.
79: 7629-7640
[Abstract]
[Full Text]
-
van den Brink, E. N., ter Meulen, J., Cox, F., Jongeneelen, M. A. C., Thijsse, A., Throsby, M., Marissen, W. E., Rood, P. M. L., Bakker, A. B. H., Gelderblom, H. R., Martina, B. E., Osterhaus, A. D. M. E., Preiser, W., Doerr, H. W., de Kruif, J., Goudsmit, J.
(2005). Molecular and Biological Characterization of Human Monoclonal Antibodies Binding to the Spike and Nucleocapsid Proteins of Severe Acute Respiratory Syndrome Coronavirus. J. Virol.
79: 1635-1644
[Abstract]
[Full Text]
-
Lewicki, D. N., Gallagher, T. M.
(2002). Quaternary Structure of Coronavirus Spikes in Complex with Carcinoembryonic Antigen-related Cell Adhesion Molecule Cellular Receptors. J. Biol. Chem.
277: 19727-19734
[Abstract]
[Full Text]
-
Krueger, D. K., Kelly, S. M., Lewicki, D. N., Ruffolo, R., Gallagher, T. M.
(2001). Variations in Disparate Regions of the Murine Coronavirus Spike Protein Impact the Initiation of Membrane Fusion. J. Virol.
75: 2792-2802
[Abstract]
[Full Text]
-
Kolb, A. F., Pewe, L., Webster, J., Perlman, S., Whitelaw, C. B. A., Siddell, S. G.
(2001). Virus-Neutralizing Monoclonal Antibody Expressed in Milk of Transgenic Mice Provides Full Protection against Virus-Induced Encephalitis. J. Virol.
75: 2803-2809
[Abstract]
[Full Text]
-
Yoo, D., Deregt, D.
(2001). A Single Amino Acid Change within Antigenic Domain II of the Spike Protein of Bovine Coronavirus Confers Resistance to Virus Neutralization. CVI
8: 297-302
[Abstract]
[Full Text]
-
Navas, S., Seo, S.-H., Chua, M. M., Sarma, J. D., Lavi, E., Hingley, S. T., Weiss, S. R.
(2001). Murine Coronavirus Spike Protein Determines the Ability of the Virus To Replicate in the Liver and Cause Hepatitis. J. Virol.
75: 2452-2457
[Abstract]
[Full Text]
-
Yoo, D., Pei, Y., Christie, N., Cooper, M.
(2000). Primary Structure of the Sialodacryoadenitis Virus Genome: Sequence of the Structural-Protein Region and Its Application for Differential Diagnosis. CVI
7: 568-573
[Abstract]
[Full Text]
-
Tsai, C.-W., Chang, S. C., Chang, M.-F.
(1999). A 12-Amino Acid Stretch in the Hypervariable Region of the Spike Protein S1 Subunit Is Critical for Cell Fusion Activity of Mouse Hepatitis Virus. J. Biol. Chem.
274: 26085-26090
[Abstract]
[Full Text]
-
Phillips, J. J., Chua, M. M., Lavi, E., Weiss, S. R.
(1999). Pathogenesis of Chimeric MHV4/MHV-A59 Recombinant Viruses: the Murine Coronavirus Spike Protein Is a Major Determinant of Neurovirulence. J. Virol.
73: 7752-7760
[Abstract]
[Full Text]
-
Arbour, N., Ekandé, S., Côté, G., Lachance, C., Chagnon, F., Tardieu, M., Cashman, N. R., Talbot, P. J.
(1999). Persistent Infection of Human Oligodendrocytic and Neuroglial Cell Lines by Human Coronavirus 229E. J. Virol.
73: 3326-3337
[Abstract]
[Full Text]
-
Arbour, N., Côté, G., Lachance, C., Tardieu, M., Cashman, N. R., Talbot, P. J.
(1999). Acute and Persistent Infection of Human Neural Cell Lines by Human Coronavirus OC43. J. Virol.
73: 3338-3350
[Abstract]
[Full Text]
-
Leparc-Goffart, I., Hingley, S. T., Chua, M. M., Phillips, J., Lavi, E., Weiss, S. R.
(1998). Targeted Recombination within the Spike Gene of Murine Coronavirus Mouse Hepatitis Virus-A59: Q159 Is a Determinant of Hepatotropism. J. Virol.
72: 9628-9636
[Abstract]
[Full Text]
-
Hingley, S. T., Leparc-Goffart, I., Weiss, S. R.
(1998). The Spike Protein of Murine Coronavirus Mouse Hepatitis Virus Strain A59 Is Not Cleaved in Primary Glial Cells and Primary Hepatocytes. J. Virol.
72: 1606-1609
[Abstract]
[Full Text]
Copyright © 1990 by the American Society for Microbiology. All rights reserved.